Kolexia
Castelnau-Marchand Corinne Gastro-entérologie
Castelnau-Marchand Corinne
Gastro-entérologie
Hôpital Beaujon
Clichy, France
59 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite B Hépatite chronique Hépatite D Hépatite C Hépatite B chronique Hépatite C chronique Fibrose Carcinome hépatocellulaire

Collaborateurs

Voir plus
Boyer-Darrigrand Nathalie
Boyer-Darrigrand Nathalie
Hôpital Beaujon, Clichy, France
Marcellin Patrick
Marcellin Patrick
Hôpital Beaujon, Clichy, France
Asselah Tarik
Asselah Tarik
Hôpital Beaujon, Clichy, France
Giuily-Guigui Nathalie
Giuily-Guigui Nathalie
Hôpital Beaujon, Clichy, France

Industries

Voir plus
Ipsen
2 collaboration(s)
Dernière en 2022
Abbvie
1 collaboration(s)
Dernière en 2022
agence européenne informatique
1 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD): A Multicenter, Open-label, Randomized Phase 3 Clinical Study to Assess Efficacy and Safety of Bulevirtide in Patients With Chronic Hepatitis Delta
Essai Clinique (Gilead)   12 septembre 2023
D-LIVR: A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
Essai Clinique (Eiger Biopharmaceuticals)   13 avril 2023
Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD): A Multicenter, Open-label, Randomized Phase 2b Clinical Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Patients With Chronic Hepatitis Delta
Essai Clinique (Gilead)   24 mars 2023
Prise en charge des varices ectopiques
Youtube @ CREGG   01 janvier 2023
Le prurit de l’hépatologue
Youtube @ CREGG   01 janvier 2023
Les grands messages de l’année 2021 en hépato
Youtube @ CREGG   01 janvier 2023
LOWR-1: An Open-label, Dose-ranging, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Lonafarnib With and Without Ritonavir Boosting in Patients Chronically Infected With Delta Hepatitis (HDV) (LOWR-1)
Essai Clinique (Eiger Biopharmaceuticals)   03 novembre 2022
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.)   16 septembre 2022
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon
Essai Clinique (National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK))   06 décembre 2021
Delta hepatitis: Epidemiology, diagnostic, natural history and treatment.
La Revue de medecine interne   17 novembre 2021